Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs

PURPOSE OF REVIEW: Human eosinophils were first identified and named by Paul Ehrlich in 1879 on the basis of the cell's granular uptake of eosin. Although eosinophils represent approximately 1% of peripheral blood leukocytes, they have the propensity to leave the blood stream and migrate into i...

Descripción completa

Detalles Bibliográficos
Autores principales: Varricchi, Gilda, Bagnasco, Diego, Borriello, Francesco, Heffler, Enrico, Canonica, Giorgio W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Special Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768650/
https://www.ncbi.nlm.nih.gov/pubmed/26859368
http://dx.doi.org/10.1097/ACI.0000000000000251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768650/
https://www.ncbi.nlm.nih.gov/pubmed/26859368
http://dx.doi.org/10.1097/ACI.0000000000000251

Ejemplares similares